NEW YORK ( TheStreet) -- Medivation (Nasdaq: MDVN) hit a new 52-week high Friday as it is currently trading at $90.59, above its previous 52-week high of $90.40 with 497,727 shares traded as of 2:05 p.m. ET. Average volume has been 753,800 shares over the past 30 days. Medivation has a market cap of $3.22 billion and is part of the health care sector and drugs industry. Shares are up 87.4% year to date as of the close of trading on Thursday. Medivation, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for the treatment of serious diseases in the United States and Europe.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!